Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
383.76
-4.00 (-1.04%)
Feb 21, 2025, 9:42 AM EST - Market open
Stryker Revenue
In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth. Stryker had revenue of $6.44B in the quarter ending December 31, 2024, with 10.68% growth.
Revenue (ttm)
$22.60B
Revenue Growth
+10.23%
P/S Ratio
6.52
Revenue / Employee
$426,321
Employees
53,000
Market Cap
146.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SYK News
- 2 days ago - Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment - GlobeNewsWire
- 7 days ago - Kadant Set to Join S&P SmallCap 600 - PRNewsWire
- 8 days ago - Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day - GlobeNewsWire
- 10 days ago - Stryker announces Allan Golston will retire from Board of Directors - GlobeNewsWire
- 20 days ago - Sales Growth, Strategic Acquisitions Drive Stryker Higher - FXEmpire
- 22 days ago - Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth - Benzinga
- 23 days ago - Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 23 days ago - Stryker forecasts 2025 profit above estimates on robust demand for surgical devices - Reuters